Correction to: ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD

Acta Neuropathol. 2019 Nov;138(5):883-884. doi: 10.1007/s00401-019-02076-y.

¹ Department of Neurobiology, Barrow Neurological Institute, 355 W Thomas Road, Phoenix, AZ, 85013, USA.
² School of Life Sciences, Arizona State University, Tempe, AZ, USA.
³ Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
⁴ Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA.
⁵ Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
⁶ Department of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Biology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
⁷ Department of Neurobiology, Barrow Neurological Institute, 355 W Thomas Road, Phoenix, AZ, 85013, USA. Rita.Sattler@Dignityhealth.org.

Abstract

The original article was published erroneously without mentioning the support of the U.S.